Multiplikator Forward P/S: Tactile Systems Technology, Inc. (TCMD)
The forward P/S multiple reflects market expectations, where 1.20 represents the current metric level. Tactile Systems Technology (TCMD) maintains stable revenue through regular sales of consumables for home lymphedema therapy systems. However, challenges may arise from revised insurance reimbursement terms and the pace of customer base expansion. The company's competitive advantage is secured by the uniqueness of its pneumatic devices for self-treatment.
Ringkesan rincian data analitis tactilemedical.com (TCMD)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Tactile Systems Technology|TCMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Tactile Medical|TCMD - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Tactile Medical|TCMD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Tactile Medical|Rasio cepet tactilemedical.com
- rincian asil keuangan lan kelipatan valuasi:
TCMD - Penghasilan resik perusahaan|Bathi sing dikarepake Tactile Systems Technology|TCMD - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Tactile Medical|TCMD - Pangali PEG|Pangali EV/EBITDA Tactile Medical|TCMD - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Tactile Medical|TCMD - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan tactilemedical.com|TCMD - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Tactile Systems Technology
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:TCMD (Tactile Systems Technology Inc.)
To assess the credit quality of Tactile Systems Technology (TCMD), the analyst compares market capitalization with projected sales volumes, utilizing the forward P/S trend to determine the asset's degree of overvaluation amid tight monetary policy. The stability of this metric is supported by the company's technological leadership in the pneumatic compression systems segment and the implementation of cloud monitoring, where a rising multiple signals inflated market expectations.
Karo sapa Tactile Systems Technology saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|SNWV: Rasio rega marang prakiraan pendapatan|OM (Outset) - Multiplikator forward rega marang pendapatan|Electromed - Rega forward marang dodolan|LNSR (LENSAR, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep avitamedical.com RCEL|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR (beyondair.net) - Multiplikator forward rega marang pendapatan|PFSA: Rasio rega marang pendapatan sing dikarepake|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S glucotrack.com|Multiplikator Forward P/S NAOV|Multiplikator forward rega marang pendapatan Venus Concept Corporation VERO|Nuwellis, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake AEMD (aethlonmedical.com)|TransEnterix - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Avinger Inc. AVGR|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|CUTR (Cutera Inc) - Rasio rega marang prakiraan pendapatan|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep inarimedical.com NARI|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
